申请人:Kyorin Seiyaku Kabushiki Kaisha
公开号:US03962249A1
公开(公告)日:1976-06-08
1-(3-Phenylpropyl)-4-furoylpiperazine represented by the following general formula (I), ##SPC1## (wherein: R.sub.1 and R.sub. 2, which may be the same or different, each represents a hydrogen atom or a lower alkyl group containing 1 to 4 carbon atoms; R.sub.3 represents a hydrogen atom, a halogen atom, a lower alkyl group containing 1 to 4 carbon atoms, or a lower alkoxy groups containing 1 to 4 carbon atoms; R.sub.4 and R.sub.5, which may be the same or different, each represents a hydrogen atom or a lower alkyl group containing 1 to 4 carbon atoms), and pharmaceutically acceptable addition salts thereof.
1-(3-苯基丙基)-4-呋喃酰基哌嗪的通用式(I)如下:##SPC1## 其中:R.sub.1和R.sub.2(可以相同也可以不同)分别表示氢原子或含有1至4个碳原子的低烷基基团;R.sub.3表示氢原子、卤素原子、含有1至4个碳原子的低烷基基团或含有1至4个碳原子的低烷氧基基团;R.sub.4和R.sub.5(可以相同也可以不同)分别表示氢原子或含有1至4个碳原子的低烷基基团。此外,还包括其药学上可接受的加合盐。